Cycrimine

Cycrimine
Clinical data
License data	US FDA: Cycrimine;
ATC code	none;
Identifiers
	IUPAC name 1-Cyclopentyl-1-phenyl-3-(piperidin-1-yl)propan-1-ol;
CAS Number	77-39-4;
PubChem CID	2911;
DrugBank	DB00942;
ChemSpider	2808;
UNII	543567RFQQ;
ChEBI	CHEBI:59692 ;
ChEMBL	ChEMBL1201227;
CompTox Dashboard (EPA)	DTXSID50861769 ;
ECHA InfoCard	100.000.932
Chemical and physical data
Formula	C19H29NO
Molar mass	287.447 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES OC(CCN1CCCCC1)(C2CCCC2)c3ccccc3;
	InChI InChI=1S/C19H29NO/c21-19(18-11-5-6-12-18,17-9-3-1-4-10-17)13-16-20-14-7-2-8-15-20/h1,3-4,9-10,18,21H,2,5-8,11-16H2; Key:SWRUZBWLEWHWRI-UHFFFAOYSA-N;

Cycrimine (trade name Pagitane) is a central anticholinergic drug designed to reduce the levels of acetylcholine in the treatment of Parkinson's disease. Its mechanism of action is to bind to the muscarinic acetylcholine receptor M1.^[1]

Synthesis

^ Usdin E, Efron DH, eds. (1979). Psychotropic Drugs and Related Compounds (2nd ed.). Washington, DC: Pergamon Press. p. 218. ISBN 978-0-08-025510-1. OCLC 715151908.
^ Denton JJ, Schedl HP, Lawson VA, Neier WB (1950). "Antispasmodics. VII.¹ Additional Morpholinyl and Piperidyl Tertiary Alcohols". Journal of the American Chemical Society. 72 (8): 3795–3796. doi:10.1021/ja01164a127.